On the other hand, studies have shown that the expression of the glutamate/cystine antiporter SLC7A11 in cancer cells is associated with reduced dependence on glutamine metabolism and increased sensitivity to glucose deprivation (304). This evidence concerns the gene SLC7A11 and cancer.